Physician profile
Thomas E Mechas
NPI 1689619553
$324.69
in general payments reported to CMS, 2019-2025
7 companies · $43.88 in 2025
The $43.88 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.71 · 2021: $13.74 · 2023: $229 · 2024: $19.87 · 2025: $43.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $161 · Food and Beverage: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $160.95 |
| Food and Beverage | $132.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $195.00 | 2023 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $33.03 | 2019-2023 | |
| Abbvie INC. | $25.14 | 2025 | |
| Amgen INC. | $19.87 | 2024 | Evenity, Prolia |
| Organon LLC | $19.17 | 2023 | Nexplanon |
| Biogen, INC. | $18.74 | 2025 | Zurzuvae |
| Urovant Sciences INC | $13.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Mechas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.